Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 3
2005 1
2006 1
2007 1
2008 3
2009 3
2010 2
2011 3
2012 4
2014 4
2016 2
2018 1
2019 1
2020 1
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer.
Heimes AS, Almstedt K, Krajnak S, Runkel A, Droste A, Schwab R, Stewen K, Lebrecht A, Battista MJ, Brenner W, Hasenburg A, Gehrmann M, Hengstler JG, Schmidt M. Heimes AS, et al. Among authors: lebrecht a. Biomedicines. 2022 Oct 21;10(10):2656. doi: 10.3390/biomedicines10102656. Biomedicines. 2022. PMID: 36289918 Free PMC article.
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer.
Almstedt K, Heimes AS, Kappenberg F, Battista MJ, Lehr HA, Krajnak S, Lebrecht A, Gehrmann M, Stewen K, Brenner W, Weikel W, Rahnenführer J, Hengstler JG, Hasenburg A, Schmidt M. Almstedt K, et al. Among authors: lebrecht a. Eur J Cancer. 2022 Sep;173:10-19. doi: 10.1016/j.ejca.2022.06.012. Epub 2022 Jul 12. Eur J Cancer. 2022. PMID: 35839597
Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer.
Almstedt K, Krauthauser L, Kappenberg F, Wagner DC, Heimes AS, Battista MJ, Anic K, Krajnak S, Lebrecht A, Schwab R, Brenner W, Weikel W, Rahnenführer J, Hengstler JG, Roth W, Hasenburg A, Stewen K, Schmidt M. Almstedt K, et al. Among authors: lebrecht a. Cancers (Basel). 2023 Feb 23;15(5):1413. doi: 10.3390/cancers15051413. Cancers (Basel). 2023. PMID: 36900203 Free PMC article.
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer.
Schmidt M, Edlund K, Hengstler JG, Heimes AS, Almstedt K, Lebrecht A, Krajnak S, Battista MJ, Brenner W, Hasenburg A, Rahnenführer J, Gehrmann M, Kellokumpu-Lehtinen PL, Wirtz RM, Joensuu H. Schmidt M, et al. Among authors: lebrecht a. Cancers (Basel). 2021 Jul 20;13(14):3626. doi: 10.3390/cancers13143626. Cancers (Basel). 2021. PMID: 34298839 Free PMC article.
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial.
Edlund K, Madjar K, Lebrecht A, Aktas B, Pilch H, Hoffmann G, Hofmann M, Kolberg HC, Boehm D, Battista M, Seehase M, Stewen K, Gebhard S, Cadenas C, Marchan R, Brenner W, Hasenburg A, Koelbl H, Solbach C, Gehrmann M, Tanner B, Weber KE, Loibl S, Sachinidis A, Rahnenführer J, Schmidt M, Hengstler JG. Edlund K, et al. Among authors: lebrecht a. Clin Cancer Res. 2021 Apr 15;27(8):2148-2158. doi: 10.1158/1078-0432.CCR-20-2662. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542080 Clinical Trial.
Diagnosis of breast cancer by tear proteomic pattern.
Lebrecht A, Boehm D, Schmidt M, Koelbl H, Schwirz RL, Grus FH. Lebrecht A, et al. Cancer Genomics Proteomics. 2009 May-Jun;6(3):177-82. Cancer Genomics Proteomics. 2009. PMID: 19487546 Free article.
41 results